PrescriptionDrugs.org

What to Expect When Starting Atomoxetine

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

Introduction

Atomoxetine (Strattera) is a non-stimulant medication for ADHD that works by selectively inhibiting the reuptake of norepinephrine. Unlike stimulant medications, atomoxetine is not a controlled substance and provides 24-hour coverage with once-daily dosing. It takes 4-8 weeks to reach full effectiveness, making it different from stimulants that work on the first day.

Week-by-week timeline

Week 1-2

Starting and Early Side Effects

Atomoxetine is usually started at a low dose (40 mg/day for adults, weight-based for children) to minimize side effects. Common early effects include decreased appetite, stomach upset, nausea, and mild insomnia. Taking it with food significantly reduces nausea. Some patients notice slight mood changes.

Week 2-4

Dose Escalation

After 2-4 weeks, the dose is typically increased toward the target (typically 80-100 mg/day for adults; up to 1.4 mg/kg/day for children/adolescents). Side effects may temporarily worsen with each dose increase. Blood pressure and heart rate should be monitored, as both can increase.

Week 4-6

Early Therapeutic Benefit

Some improvement in ADHD symptoms (concentration, impulse control, organization) may begin. Unlike stimulants, the effect is subtle and gradual — not a dramatic change felt the first day.

Week 6-8

Building Full Effect

Full therapeutic effects typically require 6-8 weeks at the target dose. Improvements in daily functioning, emotional regulation, and sustained attention become more apparent.

Month 2-3

Stability Assessment

At full therapeutic dose, assess overall benefit: Has focus improved? Is hyperactivity better managed? Atomoxetine has particular advantages for patients with anxiety comorbidity or substance abuse history, as it lacks abuse potential.

When to call your doctor

Contact your healthcare provider if you experience:

  • Thoughts of self-harm or suicide (black box warning — monitor especially in children and adolescents)
  • Worsening depression, agitation, or unusual behavior changes
  • Chest pain or palpitations
  • Signs of liver damage: yellowing of skin or eyes, dark urine, upper-right abdominal pain (rare but serious)
  • Difficulty urinating
  • Sustained erection (priapism) in males — rare but requires immediate medical attention
  • Signs of allergic reaction: rash, swelling, difficulty breathing

Tips for getting started

Take atomoxetine with food to significantly reduce nausea. If taking once daily, morning dosing is typical, but evening dosing is an option if daytime side effects are bothersome. Be patient — this medication takes 6-8 weeks to fully work, unlike stimulants. Your prescriber should monitor blood pressure, heart rate, weight, and height (in children). Atomoxetine is not habit-forming and is an appropriate choice if stimulants are not well-tolerated or there is a substance abuse concern.

Frequently asked questions

More about Atomoxetine

References

  1. [Regulatory] FDA Label: Strattera (atomoxetine HCl) Capsules https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021411s047lbl.pdf Accessed 2026-03-01.
  2. [Regulatory] NIH MedlinePlus: Atomoxetine https://medlineplus.gov/druginfo/meds/a603013.html Accessed 2026-03-01.
  3. [Regulatory] FDA Black Box Warning: Suicidal Ideation and Atomoxetine https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/strattera-atomoxetine-hydrochloride-information Accessed 2026-03-01.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: